기사 본문 영역
상세페이지
PM ON COVID-19 TREATMENT APPROVAL
입력 2021.01.14 (15:04) 수정 2021.01.14 (16:45) News Today
자동재생
동영상영역 시작
동영상영역 끝
[Anchor Lead]
Prime Minister Chung Sye-kyun says local drug maker Celltrion’s anti-COVID-19 treatment will likely obtain approval for use by early February. Its safety and efficacy are now being reviewed by the Ministry of Food and Drug Safety. The prime minister expected the medicine to effectively reduce the chances of mild cases developing into a severe stage.
Prime Minister Chung Sye-kyun says local drug maker Celltrion’s anti-COVID-19 treatment will likely obtain approval for use by early February. Its safety and efficacy are now being reviewed by the Ministry of Food and Drug Safety. The prime minister expected the medicine to effectively reduce the chances of mild cases developing into a severe stage.
- PM ON COVID-19 TREATMENT APPROVAL
-
- 입력 2021-01-14 15:04:04
- 수정2021-01-14 16:45:26
[Anchor Lead]
Prime Minister Chung Sye-kyun says local drug maker Celltrion’s anti-COVID-19 treatment will likely obtain approval for use by early February. Its safety and efficacy are now being reviewed by the Ministry of Food and Drug Safety. The prime minister expected the medicine to effectively reduce the chances of mild cases developing into a severe stage.
Prime Minister Chung Sye-kyun says local drug maker Celltrion’s anti-COVID-19 treatment will likely obtain approval for use by early February. Its safety and efficacy are now being reviewed by the Ministry of Food and Drug Safety. The prime minister expected the medicine to effectively reduce the chances of mild cases developing into a severe stage.
News Today 전체보기
- 기자 정보
-
-
KBS
-